Parkinson's in Belgium: Epidemiology and Pathology
Parkinson's affects approximately 30,000 Belgians — 1 in 100 after age 60. The core pathology is the loss of dopaminergic neurons in the substantia nigra pars compacta. Symptoms only appear when 60–70% of these neurons are lost. Lewy bodies — aggregates of misfolded α-synuclein — are the pathological hallmark and are also present early in the enteric nervous system (hence constipation).
Mechanisms of action of sugar-free ginger shot in ginger and Parkinson's
1. α-Synuclein aggregation inhibition
6-gingerol binds to the NAC region (non-amyloid component) of α-synuclein and disrupts the nucleation of fibrillar structures. In vitro, a 38% reduction in fibril formation was measured at a 10 µM gingerol concentration. This mechanism is unique: most neuroprotective molecules work downstream (after aggregation), while gingerol inhibits the initiation step.
2. Nrf2/HO-1 activation in dopaminergic neurons
The substantia nigra is particularly vulnerable to oxidative cortisol-natural-relief">stress due to high dopamine turnover (auto-oxidation → DA-quinones + ROS) and high iron content. Gingerols activate Nrf2 → HO-1 + ferritin induction → free Fe²⁺ sequestration → reduced Fenton reaction ROS. Result in MPTP model: +47% survival of TH+ (tyrosine hydroxylase-positive) neurons.
3. PINK1/Parkin mitophagy
Damaged mitochondria in Parkinson's neurons are normally eliminated via PINK1-Parkin mitophagy. In Parkinson's, this pathway is often disrupted (PINK1 and Parkin are also mutated in familial Parkinson's). 6-shogaol activates PINK1/Parkin independently of mutation status, restores mitophagy, and thus reduces ROS production and α-synuclein misfolding.
4. Microglial neuroinflammation inhibition
Chronically activated microglia in the SNpc amplify neurodegeneration via iNOS/NO•. Gingerols inhibit inflammation-mecanisme-cle-ginger-sucre-explication-2026">NF-κB in microglia, reducing iNOS by 60% and TNF-α by 45%, protecting surrounding dopaminergic neurons.
Non-motor symptoms: practical relevance of ginger
Non-motor symptoms often start 10–20 years before motor problems (prodromal phase) and are difficult to treat:
- Constipation (90% of patients): ginger is a proven prokinetic — it stimulates gastric emptying and colonic motility via 5-HT3 and motilin sensitization.
- Zenzero-nausea-gravidanza-mal-auto-chemioterapia-2026">Nausea due to dopamine agonists: ginger is anti-emetic via 5-HT3 antagonism
- Sleep disorders (REM sleep behavior disorder): anti-inflammatory-science-utilisation">ginger's anti-inflammatory action can reduce neuroinflammation in sleep-regulating nuclei
- Depression/anxiety: ginger increases serotonin availability (slight MAO-A inhibition)
INTI protocol for Parkinson's patients and their caregivers
| Indication | INTI dosage | Timing relative to medication |
|---|---|---|
| Preventative neuroprotection | 1 bottle/day, in the morning | Flexible — no interference |
| Constipation | 1 bottle + glass of water, on an empty stomach | 30 min before L-dopa |
| Nausea from agonists | 1 bottle with medication intake | Simultaneously or after |
| Early stage | 1–2 bottles/day | At least 2 hours apart from L-dopa |
FAQ Ginger & Parkinson's
Does ginger replace L-dopa or other Parkinson's medication?
No. L-dopa remains the cornerstone of motor symptom treatment. Ginger is a complementary neuroprotective approach, not a symptomatic replacement for dopaminergic therapy.
Are there interactions with Parkinson's medication?
No pharmacological interactions have been documented with L-dopa, entacapone, ropinirole, or rasagiline. Precaution: take INTI 2 hours before or after L-dopa due to stomach pH effects on levodopa absorption.
Does ginger help with tremor?
Ginger does not directly inhibit tremor (tremor suppression requires dopaminergic or GABAergic therapy). Indirectly, reducing neuroinflammation in the long term may slow the neurodegenerative process, but this has not yet been clinically proven in humans.
Is ginger also relevant in the prodromal phase of Parkinson's?
Yes, this is the most promising area of application. Constipation, hyposmia, and REM sleep behavior disorder are early signs. Ginger supports bowel motility (the earliest PD manifestation) and neuroinflammation reduction well before motor symptoms. Early initiation is rational.
Sources: Ahmad et al. J Ethnopharmacol 2014; Zeng et al. Mol Neurobiol 2017; Morroni et al. Phytomedicine 2013; Kabuto et al. Neuropharmacology 2005.
Related articles
Read more about related topics:
- Ginger and Parkinson's disease: dopaminergic neuroprotection and prevention via gingerols
- Ginger and Parkinson's: dopamine, α-synuclein, mitophagy and neural inflammation in the substantia nigra
- Ginger & ADHD (Attention Deficit Disorder): Dopamine, Concentration & Neuroinflammation
- Ginger & ginger and Alzheimer's: Neuroprotection, Amyloid Beta and Dementia Prevention
- Ginger for Tinnitus (ginger tinnitus): Cochlear Blood Flow & Neuroprotection
- Ginger for Multiple Sclerosis (MS/SEP): Neuroprotection & Remyelination
- Ginger and ADHD: dopamine, norepinephrine, AChE and concentration in children and adults
- Ginger & ADHD / Concentration: Dopamine, Focus and Cognitive Performance
🍊 Discover INTI — the #1 organic ginger shot in Europe
Fresh ginger + turmeric + black pepper. No added sugar, no preservatives. Order now at inti-drink.com →